KLF2 is a therapeutic target for COVID-19 induced endothelial dysfunction - Xu, Suowen; Luo, Sihui; Zheng, Xueying; Weng, Jianping (bioRxiv, 2021)
Keywords: Angiogenesis; Antioxidants; Atorvastatin; Coronaviruses; COVID-19; Drug therapy; Endothelial cells; Endothelium; Fibrosis; Gene expression; IL-1β; Intercellular adhesion molecule 1; Krueppel-like factor; Microvasculature; Monocytes; Nitric oxide; Patients; Pharmacology and Toxicology; Thrombosis; Transcriptomes; Tumor necrosis factor-α; Umbilical vein; Vasodilation; COVID-19; inflammation; monocyte adhesion; endothelial dysfunction; atorvastatin; KLF2